FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1

Clin Transl Med. 2022 Mar;12(3):e772. doi: 10.1002/ctm2.772.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO* / genetics
  • Colorectal Neoplasms* / drug therapy
  • Colorectal Neoplasms* / genetics
  • Humans
  • Poly (ADP-Ribose) Polymerase-1

Substances

  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO
  • FTO protein, human
  • PARP1 protein, human
  • Poly (ADP-Ribose) Polymerase-1